Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB
about
Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytesInvolvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motilityRasGRP is essential for mouse thymocyte differentiation and TCR signalingRegulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1)Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditisDistinct cAMP response element-binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination.Transcriptional regulation of interleukin 2 in SLE T cells.Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway.The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiationAntigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytesIL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508.Potential role of CREB as a prognostic marker in acute myeloid leukemia.A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia developmentTargeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells.Inhibition of activating transcription factor 1- and cAMP-responsive element-binding protein-activated transcription by an intracellular single chain Fv fragment.Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells.Modulation of Ets-1 expression in B lymphocytes is dependent on the antigen receptor-mediated activation signals and cell cycle status.LIM kinase 1 activates cAMP-responsive element-binding protein during the neuronal differentiation of immortalized hippocampal progenitor cells.Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3.Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes.Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase.Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein.Role for Ets-2(Thr-72) transcription factor in stage-specific thymocyte development and survivalThymocyte-derived BDNF influences T-cell maturation at the DN3/DN4 transition stage.Specific regulation of fos family transcription factors in thymocytes at two developmental checkpoints.Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytesE2F2 and CREB cooperatively regulate transcriptional activity of cell cycle genes.Editorial: The Molecular Mechanisms of Cyclic AMP in Regulation of Immunity and Tolerance.Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2.CRE DNA binding proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in mouse keratinocytes.Prostaglandin E2 signalling pathway in human T lymphocytes from healthy and conjunctiva basal cell carcinoma-bearing subjects.Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells.Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells.Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation.Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity.Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
P2860
Q28267702-51E8C25B-6EFA-45A6-ADCB-7442E4F38736Q28582121-234A0207-D87B-42B9-8B78-2B5828DA9CECQ28589756-4C054DF8-5C10-4F87-8B23-60E8F02D1280Q34572768-E15AA3D6-3766-416C-BCAE-2711BEFCF85FQ35041811-A1D4815E-BAD1-48BE-B1EC-F82705321A56Q35273904-870BF5BF-2816-4796-9F8B-79D5385C78C1Q35675723-E0C9047C-EE86-49C7-AAE0-8C907F9C5120Q35809422-020F6357-739D-4EBA-92F7-8CCA81D1B2F8Q35925314-A375EC30-E235-4E86-9878-3B438BA1E83FQ35985303-FF0D87CB-0835-4886-B719-D8CEF91D9203Q36375520-04602C70-73D1-4E3D-8C62-479C418ACC67Q36403717-009CCAF4-515D-4F7D-B52D-C27EC6BF5680Q36895824-AA2D6455-E1A3-417B-9A5A-EA58F28581AAQ37024235-3C377E6F-BD85-4DC3-B054-5D6442654BA9Q38301703-7188F6AE-C33E-4602-B0B4-EDE4128B8B79Q38336113-27D7EFFE-B11C-43C9-A1CC-EDE277E500C5Q38362114-0ED0B83A-D55D-4F3A-93A7-8B7067143D62Q39231732-49F8B2DE-6147-48EA-9FAB-E6B31F2B4C63Q40605915-59F60065-9390-4E79-B330-8D6C7B6A8315Q40701095-0BF9A2BD-6524-4909-AB0B-3990F10B8DD6Q40761200-AAA97CB9-9DAB-4EF5-85D1-0D538D9BF990Q40808356-60AD2B0E-B0B4-45D6-98EC-D96D9CAEA14DQ40833834-924E5C30-D5BB-4CC1-AE7F-D3AEE5BBA80AQ40928862-C9A6D847-4A55-415E-8353-4958A1F18628Q41479119-805ED601-98BB-426F-977E-93E0E7364445Q41517658-B79A0C2E-1CD5-46A8-932B-A93CD3DDAD38Q41665482-07BB1B81-4457-4E51-8C2A-8D4CDB618CE7Q41763674-8A70C40A-7214-4CD2-A35B-E577C3B82C40Q41898343-B1125726-75FE-4747-96D1-2BBAF1507722Q42324015-96A5515A-9E97-4FA9-BC5E-E8DA280F58CFQ42448867-1C694C70-7FFB-475C-A971-6836FFF347B5Q42470001-B17F9054-11B7-458A-ACAE-5A7D0AE02E44Q42510336-0B0C1808-8037-46FC-9869-455AEF9FADDAQ43688069-AB2326AE-6C40-4A13-8729-6D860FA383DAQ43925886-4FE62022-96AF-4DFB-98FC-A7CF822951EEQ44755132-EECB43C0-BC10-461E-AC6C-8FF589FAE956Q45042358-40A3875D-451C-4868-90D7-D6858541AF90Q45266653-19FF69A1-6802-4BD2-AFC5-CACC5DFB2F5DQ45345853-BA9ED043-EAD2-4BE4-90D3-0F6BD4A2F8F0Q47203264-EC6244C5-5750-4430-BEDA-990794880463
P2860
Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в січні 1996
@uk
name
Defective thymocyte proliferat ...... dominant-negative form of CREB
@en
Defective thymocyte proliferat ...... dominant-negative form of CREB
@nl
type
label
Defective thymocyte proliferat ...... dominant-negative form of CREB
@en
Defective thymocyte proliferat ...... dominant-negative form of CREB
@nl
prefLabel
Defective thymocyte proliferat ...... dominant-negative form of CREB
@en
Defective thymocyte proliferat ...... dominant-negative form of CREB
@nl
P2093
P356
P1433
P1476
Defective thymocyte proliferat ...... dominant-negative form of CREB
@en
P2093
Chanyangam M
Clendenin C
Muthusamy N
P2888
P356
10.1038/379081A0
P407
P577
1996-01-01T00:00:00Z
P6179
1012677783